Major age-related changes of mouse hematopoietic stem/progenitor cells

Annals of the New York Academy of Sciences

Volumn 996, Issue , 2003, Pages 195-208

  Kim, Mijung ^a   Moon, Hee Bom ^b   Spangrude, Gerald J ^c,d  

^a Asan Institute for Life Sciences   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL CELL; B LYMPHOCYTE; CELL CYCLE; CELL FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; NONHUMAN; PHENOTYPE; STEM CELL;

ANIMALIA;

EID: 0038806560     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03247.x     Document Type: Conference Paper

References (37)

1. HAYFLICK, L. 1976. The cell biology of human aging. N. Engl. J. Med. 295: 1302-1308.
2. MICKLEM, H.S. et al. 1972. Competitive in vivo proliferation of foetal and adult haematopoietic cells in lethally irradiated mice. J. Cell Physiol. 79: 293-298.
3. ALBRIGHT, J.W. & T. MAKINODAN. 1976. Decline in the growth potential of spleen-colonizing bone marrow stem cells of long-lived aging mice. J. Exp. Med. 144: 1204-1213.
4. MAUCH, P. et al. 1982. Decline in bone marrow proliferative capacity as a function of age. Blood 60: 245-252.
5. MORRISON, S.J. et al. 1996. The aging of hematopoietic stem cells. Nature Med 2: 1011-1016.
6. HARRISON, D.E. & C.M. ASTLE. 1982. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J. Exp. Med. 156: 1767-1779.
7. HARRISON, D.E., C.M. ASTLE & M. STONE. 1989. Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. J. Immunol. 142: 3833-3840.
8. CHEN, J., C.M. ASTLE & D.E. HARRISON. 2000. Genetic regulation of primitive hematopoietic stem cell senescence. Exp. Hematol. 28: 442-450.
9. MORRISON, S.J. et al. 1996. Telomerase activity in hematopoietic cells is associated with self- renewal potential. Immunity 5: 207-216.
10. YUI, J., C.P. CHIU & P.M. LANSDORP. 1998. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91: 3255-3262.
11. PHILLIPS, R L., A.J. REINHART & G. VAN ZANT. 1992. Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc. Natl. Acad. Sci. (USA) 89: 11607-11611.
12. LANSDORP, P.M., W. DRAGOWSKA & H. MAYANI. 1993. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J. Exp. Med.178: 787-791.
13. BERTONCELLO, I., G.S. HODGSON & T.R. BRADLEY. 1985. Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp. Hematol. 13: 999-1006.
14. SPANGRUDE, G.J. & G.R. JOHNSON. 1990. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc. Natl. Acad. Sci. (USA) 87: 7433-7437.
15. JOHNSON, L.V., M.L. WALSH & L.B. CHEN. 1980. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. (USA) 77: 990-994.
16. PLOEMACHER, R.E. & N.H.C. BRONS. 1988. Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention. J. Cell Physiol. 136: 531-536.
17. CHAUDHARY, P.M. & I.B. RONINSON. 1991. Expression and activity of P-Glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85-94.
18. ZHOU, S. et al. 2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7: 1028-1034.
19. KIM, M. J. et al. 1998. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 91: 4106-4117.
20. WITKOWSKI, J.M. & R.A. MILLER. 1993. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J. Immunol. 150: 1296-1306.
21. PILARSKI, L.M. et al. 1995. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging. Am. J. Hematol. 49: 323-335.
22. LELONG, I.H. et al. 1991. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol. Pharmacol. 40: 490-494.
23. SPANGRUDE, G.J., D.M. BROOKS & D.B. TUMAS. 1995. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85: 1006-1016.
24. SLAYTON, W.B. et al. 2002. The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells. Blood 100: 3975-3982.
25. TANG WAI, D.F. et al. 1995. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochem. 34: 32-39.
26. SPANGRUDE, G.J., S. HEIMFELD & I.L. WEISSMAN. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
27. CHEN, J., C.M. ASTLE & D.E. HARRISON. 1999. Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp. Hematol. 27: 928-935.
28. RANDALL, T.D. & I.L. WEISSMAN. 1998. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Stem Cells 16: 38-48.
29. FARRAR, J.J., B.E. LOUGHMAN & A.A. NORDIN. 1974. Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and aged mice. J. Immunol. 112: 1244-1249.
30. FRANCUS, T. et al. 1986. Effect of age on the capacity of the bone marrow and the spleen cells to generate B lymphocytes. J. Immunol. 137: 2411-2417.
31. SHARP, A. et al. 1989. Age related changes in hemopoietic capacity of bone marrow cells. Mech. Ageing Dev. 48: 91-99.
32. VAN ZANT, G., G. DE HAAN & I. N. RICH. 1997. Alternatives to stem cell renewal from a developmental viewpoint. Exp. Hematol. 25: 187-192.
33. SUDO, K., et al. 2000. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 192: 1273-1280.
34. GOODELL, M.A., et al. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183: 1797-1806.
35. ZHOU, S., et al. 2002. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 99: 12339-12344.
36. MORRISON, S.J. & I.L. WEISSMAN. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1: 661-673.
37. GOODELL, M.A. et al. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3: 1337-1345.